BGM Group (NASDAQ:BGM) Stock Price Down 1.1% – Time to Sell?

BGM Group Ltd. (NASDAQ:BGM) dropped 1.1% during trading on Wednesday . The company traded as low as $0.3508 and last traded at $0.3635. Approximately 24,276 shares changed hands during mid-day trading, a decline of 96% from the average session volume of 601,856 shares. The stock had previously closed at $0.3676.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of BGM Group in a research note on Monday, April 20th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock currently has a consensus rating of “Sell”.

BGM Group Price Performance

The company has a fifty day moving average price of $0.33 and a two-hundred day moving average price of $1.44.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Marshall Wace LLP acquired a new position in BGM Group in the second quarter valued at $218,000. Mariner LLC acquired a new stake in shares of BGM Group during the third quarter worth about $267,000. Finally, Geode Capital Management LLC purchased a new position in shares of BGM Group during the second quarter worth about $412,000.

BGM Group Company Profile

Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions.